No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr17:38668400-38680600 |
Weak transcription |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
2 |
chr17:38671400-38679800 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
3 |
chr17:38672600-38680800 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
4 |
chr17:38674200-38681200 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
5 |
chr17:38675400-38680800 |
Enhancers |
HMEC |
breast
|
6 |
chr17:38675600-38686600 |
Weak transcription |
Primary T cells effector/memory enriched fromperipheralblood |
blood
|
7 |
chr17:38677000-38679600 |
Enhancers |
Dnd41 |
blood
|
8 |
chr17:38677000-38680800 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
9 |
chr17:38677200-38679800 |
Enhancers |
Esophagus |
oesophagus
|
10 |
chr17:38677400-38679800 |
Weak transcription |
Primary B cells from cord blood |
blood
|
11 |
chr17:38677600-38682200 |
Weak transcription |
Spleen |
Spleen
|
12 |
chr17:38677600-38687800 |
Weak transcription |
Right Ventricle |
heart
|
13 |
chr17:38677800-38680600 |
Weak transcription |
Primary T helper cells fromperipheralblood |
blood
|
14 |
chr17:38678000-38683000 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
15 |
chr17:38678000-38686800 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
16 |
chr17:38678200-38679600 |
Weak transcription |
Primary B cells from peripheral blood |
blood
|
17 |
chr17:38678200-38679600 |
Weak transcription |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
18 |
chr17:38678200-38684200 |
Weak transcription |
Primary Natural Killer cells fromperipheralblood |
blood
|
19 |
chr17:38678200-38685200 |
Weak transcription |
Primary T helper 17 cells PMA-I stimulated |
--
|
20 |
chr17:38678400-38679600 |
Enhancers |
A549 |
lung
|
21 |
chr17:38678400-38680000 |
Enhancers |
Hela-S3 |
cervix
|
22 |
chr17:38678400-38680400 |
Weak transcription |
NHDF-Ad |
bronchial
|
23 |
chr17:38678600-38681800 |
Weak transcription |
HSMM |
muscle
|
24 |
chr17:38678600-38684200 |
Weak transcription |
Primary T helper naive cells from peripheral blood |
blood
|
25 |
chr17:38678800-38679600 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
26 |
chr17:38678800-38680200 |
Genic enhancers |
NHEK |
skin
|
27 |
chr17:38678800-38686800 |
Weak transcription |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
28 |
chr17:38679000-38682800 |
Weak transcription |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
29 |
chr17:38679200-38680400 |
Weak transcription |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
30 |
chr17:38679200-38680400 |
Weak transcription |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
31 |
chr17:38679200-38680600 |
Weak transcription |
Primary T cells from cord blood |
blood
|
32 |
chr17:38679200-38680800 |
Weak transcription |
HSMMtube |
muscle
|
33 |
chr17:38679200-38684200 |
Weak transcription |
Primary T helper memory cells from peripheral blood 2 |
blood
|
34 |
chr17:38679200-38686600 |
Weak transcription |
Muscle Satellite Cultured Cells |
--
|
35 |
chr17:38679200-38686800 |
Weak transcription |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
36 |
chr17:38679400-38679600 |
Enhancers |
Stomach Mucosa |
stomach
|
37 |
chr17:38679400-38679800 |
Flanking Active TSS |
Placenta |
Placenta
|
38 |
chr17:38679400-38680800 |
Genic enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
39 |
chr17:38679400-38681400 |
Enhancers |
HepG2 |
liver
|
40 |
chr17:38679400-38681600 |
Weak transcription |
Primary T cells fromperipheralblood |
blood
|